AI assistant
ELI LILLY & Co — Director's Dealing 2022
Feb 3, 2022
29745_dirs_2022-02-03_fd0f1c0e-e749-4871-a6fc-6bbaee8820aa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2021-12-31
Reporting Person: Ricks David A (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-28 | Common Stock | G | 63500 | — | Disposed | 376744 | Direct |
| 2021-10-28 | Common Stock | G | 8000 | — | Disposed | 368744 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 63500 | Indirect |
| Common Stock | 7085 | Indirect |
Footnotes
F1: On April 28, 2021, the Reporting Person transferred 63,500 shares of Eli Lilly and Company common stock to a spousal lifetime access trust, of which the Reporting Person's wife is the trustee and the Reporting Person's wife and children are beneficiaries. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose.